Medically reviewed by Matthew Wosnitzer, MD Key Takeaways The main tests for kidney disease are an estimated glomerular filtration rate (eGFR) blood test and a urine albumin-to-creatinine ratio (UACR) ...

Hello everyone, how are you doing? It's Tamako! 🐱💊"Since the creatinine isn't high, is this dosage okay?""If the eGFR is ...

Launch expands AstraZeneca’s commitment to addressing substantial unmet need across the spectrum of EGFR-mutated lung cancer ...

ZEGFROVY is now available in the US for post-platinum EGFR exon 20 insertion NSCLC after a 46% response rate in WU-KONG1B.

Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through ...

GLP-1 receptor agonists have been found to potentially reduce the risk of certain patients requiring major kidney treatment.

Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today presented new biomarker data from the Phase 3 PROTECT Study providing evidence that FILSPARI® (sparsentan) may modify the underlying disease ...

Chronic Kidney Disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste ...

In a cross-sectional study of 240 patients with chronic kidney disease, higher serum BDNF levels and a ...

In December 2025, Johnson & Johnson completed its acquisition of Halda Therapeutics, adding JNJ-6143 and the RIPTAC platform to its oncology portfolio.

Two oral presentations to highlight new 76-week data showing sustained proteinuria reduction and continued eGFR stabilization with a consistent ...